Tag Archives: NeuralStem

NeuralStem ALS Results

NeuralStem’s results from their 15pt, open-label trial of neural stem cells (fetal source) in ALS proved to be both ambiguous and controversial. Since there was no control group, NeuralStem parsed the treatment sample into two cohorts, those who appeared to … Continue reading

Posted in BioFollies, Biotech | Tagged , | Leave a comment

NeuralStem and the ‘Right-To Try’

Colorado has recently passed ‘Right-to-Try’ (RTT) legislation permitting companies to offer experimental treatments for fatal diseases that have not been FDA approved—and the requirement of payment is permitted if the Company so chooses. The criterion is that they have reached … Continue reading

Posted in BioFollies, Biotech, Muddled Media | Tagged , , , | Leave a comment